Patient preference after switching guselkumab from prefilled syringe to an autoinjection pen in psoriasis and psoriatic arthritis patients.

Autor: Borrás-Blasco J; Servicio de Farmacia, Hospital Sagunto, Sagunto, Valencia, España. Electronic address: jborrasb@gmail.com., Alcalá García R; Servicio de Farmacia, Hospital Sagunto, Sagunto, Valencia, España., Cornejo-Uixeda S; Servicio de Farmacia, Hospital Sagunto, Sagunto, Valencia, España., Matellanes-Palacios M; Servicio de Farmacia, Hospital Sagunto, Sagunto, Valencia, España., Casterá-Melchor E; Servicio de Farmacia, Hospital Sagunto, Sagunto, Valencia, España.

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.

Biosimilars and access to biologic therapy in immune-mediated diseases.

Autor: Vázquez-Sánchez R; Hospital Pharmacy Department, Getafe University Hospital, Getafe, Madrid, Spain., Navarro-Dávila M; Hospital Pharmacy Department, Canary Islands University Complex, Las Palmas de Gran Canaria, Spain., Herráiz ER; Hospital Pharmacy Department, La Princesa University Hospital, Madrid, Spain., Merino-Bohórquez V; Hospital Pharmacy Department, Virgen Macarena University Hospital, Seville, Spain., Borrás-Blasco J; Hospital Pharmacy Department, Sagunto Hospital, Sagunto, Valencia, Spain., Onteniente-González A; Hospital Pharmacy Department, Getafe University Hospital, Getafe, Madrid, Spain., Iglesias-Lambarri A; Hospital Pharmacy Department, Galdakao Hospital, Durango, Vizcaya, Spain., Negro-Vega E; Hospital Pharmacy Department, Getafe University Hospital, Getafe, Madrid, Spain.

Publikováno v: Expert opinion on biological therapy [Expert Opin Biol Ther] 2024 Jul; Vol. 24 (7), pp. 647-653. Date of Electronic Publication: 2024 May 14.

Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study.

Autor: Galindo Izquierdo M; Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Borrás Blasco J; Hospital Pharmacy, Hospital de Sagunto, Sagunto, Spain., Pérez Ortega S; President of FELUPUS (Spanish Lupus Federation), Madrid, Spain., Salman-Monte TC; Rheumatology Department, Hospital del Mar, Barcelona, Spain., Vela-Casasempere P; Rheumatology Department, Hospital General Universitario Dr Balmis Alicante/ISABIAL/Universidad Miguel Hernandez, Alicante, Spain., Rodríguez Almaraz E; Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Calvo-Alen J; Rheumatology Department, Hospital Universitario Araba, Instituto de Investigación BIORABA, Universidad del País Vasco, Vitoria-Gasteiz, Spain., Álvaro-Gracia Álvaro JM; Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Barbado Ajo MJ; Internal Medicine Department, Hospital Universitario Rio Hortega, Valladolid, Spain., Rubio Renau R; Evidence Generation Department, A Piece of Pie, Barcelona, Spain., Galvez-Fernandez M; Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain., Bahamontes-Rosa N; Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain., Sánchez-Covisa Hernández J; Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain., Solà Marsiñach C; Evidence Generation Department, A Piece of Pie, Barcelona, Spain.

Publikováno v: Lupus [Lupus] 2024 Jun; Vol. 33 (7), pp. 663-674. Date of Electronic Publication: 2024 Apr 05.

Persistence, current state of the art.

Autor: Rodriguez Goicoechea M; Servicio de Farmacia, Complejo Hospitalario de Jaén, Andalucía, España., Tejedor Tejada E; Servicio de Farmacia, Hospital Clínic, Barcelona, España. Electronic address: edutejedor91@gmail.com., Borrás Blasco J; Servicio de Farmacia, Hospital de Sagunto, Valencia, España.

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 May-Jun; Vol. 48 (3), pp. 141. Date of Electronic Publication: 2023 Sep 25.

Six months multicentre pilot open label single-arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA® e-Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients.

Autor: Borrás-Blasco J; Pharmacy Service, Hospital de Sagunto, Sagunto, Spain., Vicente-Escrig E; Pharmacy Service, Hospital General Universitario de Castellón, Castellón, Spain., Rodríguez-Lucena FJ; Pharmacy Service, Hospital Vega Baja, Orihuela, Spain., García-Monsalve A; Pharmacy Service, Hospital General Universitario de Elche, Elche, Spain., Arroyo-Domingo E; Pharmacy Service, Hospital Vega Baja, Orihuela, Spain., Ferrando-Piqueres R; Pharmacy Service, Hospital General Universitario de Castellón, Castellón, Spain., Casterá E; Pharmacy Service, Hospital de Sagunto, Sagunto, Spain., Navarro-Ruiz A; Pharmacy Service, Hospital General Universitario de Elche, Elche, Spain.

Publikováno v: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Dec; Vol. 47 (12), pp. 2345-2349. Date of Electronic Publication: 2022 Dec 05.